Brazil to be self-reliant in efavirenz production
This article was originally published in Scrip
Executive Summary
Brazil may soon be self-reliant in the production of efavirenz, says the country's ministry of health. The news comes after the state-owned pharmaceutical lab, Farmanguinhos, announced positive bioavailability test results for its generic version ofMerck Sharp & Dohme's Stocrin (efavirenz).